ADT Inc. (ADT)
NYSE: ADT · Real-Time Price · USD
8.33
+0.03 (0.36%)
At close: May 9, 2025, 4:00 PM
8.48
+0.15 (1.83%)
After-hours: May 9, 2025, 7:30 PM EDT
ADT Inc. Revenue
ADT Inc. had revenue of $1.27B in the quarter ending March 31, 2025, with 6.54% growth. This brings the company's revenue in the last twelve months to $4.98B, up 5.65% year-over-year. In the year 2024, ADT Inc. had annual revenue of $4.90B with 5.28% growth.
Revenue (ttm)
$4.98B
Revenue Growth
+5.65%
P/S Ratio
1.49
Revenue / Employee
$388,771
Employees
12,800
Market Cap
6.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.90B | 245.62M | 5.28% |
| Dec 31, 2023 | 4.65B | 270.92M | 6.18% |
| Dec 31, 2022 | 4.38B | 179.18M | 4.26% |
| Dec 31, 2021 | 4.20B | -1.11B | -20.92% |
| Dec 31, 2020 | 5.31B | 189.13M | 3.69% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| RTX Corporation | 81.74B |
| Lockheed Martin | 71.81B |
| The Boeing Company | 69.44B |
| Caterpillar | 63.26B |
| Deere & Company | 47.86B |
| General Electric Company | 39.68B |
| Honeywell International | 39.22B |
| GE Vernova | 35.71B |
ADT News
- 10 days ago - ADT and Yale Introduce First-Ever Z-Wave User Credential Command Class Lock, Expanding Smart Home Security with Fingerprint Control - GlobeNewsWire
- 11 days ago - AUA 2025: New Data from Post-Hoc Analyses Shared on Ultra-Low Prostate-Specific Antigen (PSA) Response in Patients with Metastatic Hormone-Sensitive Prostate Cancer Receiving NUBEQA® (darolutamide) plus Androgen Deprivation Therapy (ADT) - Business Wire
- 11 days ago - ADT: Solid Quarter Adds Confidence To Potential Growth Acceleration - Seeking Alpha
- 15 days ago - ADT Inc. (ADT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - ADT Reports First Quarter 2025 Results - GlobeNewsWire
- 24 days ago - Best Cheap Stocks To Buy Now (Under $10) - Kiplinger
- 4 weeks ago - ADT To Release First Quarter 2025 Results On Thursday, April 24, 2025 - GlobeNewsWire
- 6 weeks ago - ADT Strengthens Executive Leadership Team with Appointments of Fawad Ahmad as Chief Operating and Customer Officer and Omar Khan as Chief Business Officer - GlobeNewsWire